Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.08M Sell
40,567
-200
-0.5% -$10.6K 0.03% 325
2023
Q2
$2.34M Buy
40,767
+85
+0.2% +$4.96K 0.03% 322
2023
Q1
$2.45M Buy
40,682
+22
+0.1% +$1.34K 0.04% 318
2022
Q4
$2.39M Sell
40,660
-249
-0.6% -$15.8K 0.03% 341
2022
Q3
$2.34M Buy
40,909
+2,853
+7% +$166K 0.04% 311
2022
Q2
$2.06M Buy
38,056
+6,289
+20% +$365K 0.04% 323
2022
Q1
$1.83M Buy
+31,767
New +$1.62M 0.03% 367
2019
Q3
Sell
-32,031
Closed -$947K 703
2019
Q2
$947K Buy
+32,031
New +$862K 0.03% 389

Other funds holding CTVA

Colony Group's CTVA Position: Q3 2023 in Review

Colony Group reduced its Corteva (CTVA) stake by 0.49% in Q3 2023, selling an estimated $10.6K and leaving 40,567 shares worth $2.08M. The position accounts for 0.03% of the portfolio, ranked #325.

Colony Group first reported a position in CTVA in Q2 2019 and has held it in 8 quarters since. The position peaked at $2.45M in Q1 2023. 1,195 funds tracked by Wall St. Rank hold CTVA as of Q3 2023.

  • Colony Group held 40,567 shares of Corteva worth $2.08M as of Q3 2023.
  • Colony Group sold 200 Corteva shares in Q3 2023, an estimated $10.6K.
  • Corteva made up 0.03% of Colony Group's portfolio in Q3 2023, its #325 holding.
  • Colony Group first reported a position in Corteva in Q2 2019 and has held it in 8 quarters since.
  • Colony Group's Corteva position peaked at $2.45M in Q1 2023.
  • 1,195 funds tracked by Wall St. Rank held Corteva as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.